Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$3.29
+2.5%		$3.28
$2.87
▼
$10.52
$262.03M2.09653,257 shs498,283 shs
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
$14.21
+2.1%		$18.99
$12.97
▼
$28.14
$250.04M0.88245,672 shs240,634 shs
Solesence, Inc. stock logo
SLSN
Solesence
$0.95
-0.5%		$0.90
$0.61
▼
$4.55
$67.11M1.2521,180 shs5,055 shs
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$14.06
-0.3%		$18.84
$12.57
▼
$32.29
$259.42M0.73248,611 shs150,415 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
0.00%+2.49%-0.90%-14.77%-66.33%
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
0.00%-0.91%-29.97%-33.22%-15.82%
Solesence, Inc. stock logo
SLSN
Solesence
0.00%0.00%+15.85%-22.76%-73.54%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
0.00%+4.38%-36.57%-23.40%-56.21%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$3.29
+2.5%		$3.28
$2.87
▼
$10.52
$262.03M2.09653,257 shs498,283 shs
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
$14.21
+2.1%		$18.99
$12.97
▼
$28.14
$250.04M0.88245,672 shs240,634 shs
Solesence, Inc. stock logo
SLSN
Solesence
$0.95
-0.5%		$0.90
$0.61
▼
$4.55
$67.11M1.2521,180 shs5,055 shs
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$14.06
-0.3%		$18.84
$12.57
▼
$32.29
$259.42M0.73248,611 shs150,415 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
0.00%+2.49%-0.90%-14.77%-66.33%
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
0.00%-0.91%-29.97%-33.22%-15.82%
Solesence, Inc. stock logo
SLSN
Solesence
0.00%0.00%+15.85%-22.76%-73.54%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
0.00%+4.38%-36.57%-23.40%-56.21%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
3.00
Buy$10.33214.08% Upside
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
2.67
Moderate Buy$30.50114.64% Upside
Solesence, Inc. stock logo
SLSN
Solesence
1.00
SellN/AN/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest SLSN, NAGE, USNA, and NATR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/18/2026
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C+) ➝ Hold (C)
8/10/2026
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
DA Davidson logo
DA Davidson
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$33.00 ➝ $25.00
8/6/2026
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
8/5/2026
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
8/5/2026
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$10.00
7/30/2026
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$37.00 ➝ $36.00
7/28/2026
Solesence, Inc. stock logo
SLSN
Solesence
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D+) ➝ Sell (D)
7/17/2026
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
7/13/2026
Solesence, Inc. stock logo
SLSN
Solesence
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D) ➝ Sell (D+)
7/6/2026
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
Freedom Capital logo
Freedom Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
7/6/2026
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
DA Davidson logo
DA Davidson
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 8/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$129.42M2.02$0.20 per share16.22$1.04 per share3.16
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
$480.14M0.52$2.17 per share6.54$9.62 per share1.48
Solesence, Inc. stock logo
SLSN
Solesence
$62.06M1.08$0.04 per share24.94$0.19 per share5.00
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$925.26M0.28$4.14 per share3.40$28.49 per share0.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$17.38M$0.1818.2823.50N/A12.39%17.95%13.17%N/A
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
$19.52M$1.0114.07N/AN/A3.68%12.88%8.17%11/9/2026 (Estimated)
Solesence, Inc. stock logo
SLSN
Solesence
$1.79M-$0.03N/AN/AN/A-3.40%-11.58%-3.79%N/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$10.76M-$1.21N/A7.941.54-2.43%3.41%2.50%10/28/2026 (Estimated)

Latest SLSN, NAGE, USNA, and NATR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
$0.27$0.21-$0.06$0.19$123.70 million$116.99 million
8/4/2026Q2 2026
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
$0.01$0.01N/A$0.01$29.95 million$29.78 million
8/4/2026Q2 2026
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
$0.43-$0.07-$0.50-$1.16$235.00 million$223.27 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
N/AN/AN/AN/AN/A
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
N/AN/AN/AN/AN/A
Solesence, Inc. stock logo
SLSN
Solesence
N/AN/AN/AN/AN/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
N/A
6.50
5.13
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
N/A
2.60
1.55
Solesence, Inc. stock logo
SLSN
Solesence
N/A
0.97
0.47
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
N/A
2.66
1.84

Institutional Ownership

CompanyInstitutional Ownership
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
15.41%
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
79.40%
Solesence, Inc. stock logo
SLSN
Solesence
70.22%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
54.25%

Insider Ownership

CompanyInsider Ownership
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
10.00%
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
3.10%
Solesence, Inc. stock logo
SLSN
Solesence
4.80%
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
0.82%
CompanyEmployeesShares OutstandingFree FloatOptionable
Niagen Bioscience, Inc. stock logo
NAGE
Niagen Bioscience
12079.64 million71.68 millionN/A
Nature's Sunshine Products, Inc. stock logo
NATR
Nature's Sunshine Products
85017.60 million17.05 millionOptionable
Solesence, Inc. stock logo
SLSN
Solesence
6070.65 million67.26 millionN/A
USANA Health Sciences, Inc. stock logo
USNA
USANA Health Sciences
1,57018.48 million18.33 millionOptionable

Recent News About These Companies

Nantahala Capital Management LLC Acquires New Position in USANA Health Sciences, Inc. $USNA
August 29 at 6:37 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-nantahala-capital-management-llc-acquires-new-position-in-usana-health-sciences-inc-usna-2026-08-29/
USANA Health Sciences : USNA
August 26, 2026  |  247wallst.comhttps://247wallst.com/companies/usna/
1,205,587 Shares in USANA Health Sciences, Inc. $USNA Bought by Pzena Investment Management LLC
August 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-1205587-shares-in-usana-health-sciences-inc-usna-bought-by-pzena-investment-management-llc-2026-08-18/
USANA Introduces 3-in-1 Protein, Creatine, and Electrolyte Drink Mix
August 17, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/usana-introduces-3-in-1-protein-creatine-and-electrolyte-drink-mix-302852241.html
USANA Health Sciences Trims Outlook Amid Brand Headwinds
August 14, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/USNA-N/pressreleases/3817530/usana-health-sciences-trims-outlook-amid-brand-headwinds/
5 must-read analyst questions from USANA’s Q2 earnings call
August 11, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/5-must-read-analyst-questions-from-usana-s-q2-earnings-call/ar-AA29P2uC
Sidoti Raises Earnings Estimates for USANA Health Sciences
August 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sidoti-raises-earnings-estimates-for-usana-health-sciences-2026-08-10/
Why Usana Health Sciences Stock Plummeted This Week
August 9, 2026  |  fool.comhttps://www.fool.com/investing/2026/08/09/why-usana-health-sciences-stock-plummeted-this-wee/
USANA Health Sciences Q2 Earnings Call Highlights
August 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/usana-health-sciences-q2-earnings-call-highlights-2026-08-09/
USANA Health Sciences (NYSE:USNA) Rating Lowered to Strong Sell at Zacks Research
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/usana-health-sciences-nyseusna-rating-lowered-to-strong-sell-at-zacks-research-2026-08-08/
USANA Health Sciences (NYSE:USNA) Cut to "Hold" at Wall Street Zen
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/usana-health-sciences-nyseusna-cut-to-hold-at-wall-street-zen-2026-08-08/
Sidoti Brokers Decrease Earnings Estimates for USNA
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sidoti-brokers-decrease-earnings-estimates-for-usna-2026-08-07/
Why USANA (USNA) stock is nosediving
August 5, 2026  |  msn.comhttps://www.msn.com/en-us/health/general/why-usana-usna-stock-is-nosediving/ar-AA29sqAR
USANA signals $29M Hiya goodwill impairment while lowering 2026 outlook
August 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4626592-usana-signals-29m-hiya-goodwill-impairment-while-lowering-2026-outlook
USANA Health Sciences, Inc. (USNA) Q2 2026 Earnings Call Transcript
August 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4931129-usana-health-sciences-inc-usna-q2-2026-earnings-call-transcript
USANA Health Sciences: No Clear Growth Engine Left (Rating Downgrade)
August 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4931073-usana-health-sciences-no-clear-growth-engine-left-rating-downgrade?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
USANA Chairman, CEO Kevin Guest Shares 5 Ways to Make Happiness Happen at Work and Home This August
August 5, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/usana-chairman-ceo-kevin-guest-shares-5-ways-to-make-happiness-happen-at-work-and-home-this-august-302840975.html
Lazard Asset Management LLC Invests $1.26 Million in USANA Health Sciences, Inc. $USNA
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-lazard-asset-management-llc-invests-126-million-in-usana-health-sciences-inc-usna-2026-08-05/
USANA Health: Q2 Earnings Snapshot
August 5, 2026  |  seattlepi.comS
USANA (NYSE:USNA) misses Q2 CY2026 sales expectations, stock drops 19.2%
August 5, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/usana-nyse-usna-misses-q2-cy2026-sales-expectations-stock-drops-19-2/ar-AA29pdtD
USANA Health Sciences (USNA) Reports Q2 Loss, Lags Revenue Estimates
August 4, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2968050/usana-health-sciences-usna-reports-q2-loss-lags-revenue-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2968050

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Solventum logo with a green S icon on a light blue background featuring medical cross and network graphics.
Solventum Nears Inflection Point As It Begins to Unlock Value
By Thomas Hughes | August 7, 2026
AMG logo displayed on a glass sign in an office building lobby with a city skyline visible outside.
AMG’s Alternatives Boom Powers Record Growth
By Peter Frank | August 16, 2026
Illuminated Marriott logo and sign at the entrance of a hotel building at dusk.
Marriott’s Earnings Drop May Be Missing the Bigger Fee Growth Story
By Chris Markoch | August 4, 2026
CVS Health logo displayed above a pharmacy counter with prescription bottles and a bandage box on the counter.
One Comment on CVS's Earnings Call Sent the Stock Tumbling
By Chris Markoch | August 7, 2026
Gold Bitcoin tokens float around the Strategy logo, underscoring its renewed push to buy more digital assets.
Strategy's Structural Strength: Hidden in a $8 Billion Illusion
By Jeffrey Neal Johnson | August 2, 2026
Niagen Bioscience stock logo

Niagen Bioscience NASDAQ:NAGE

$3.29 +0.08 (+2.49%)
As of 08/28/2026 04:00 PM Eastern

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Nature's Sunshine Products stock logo

Nature's Sunshine Products NASDAQ:NATR

$14.21 +0.29 (+2.08%)
As of 08/28/2026 04:00 PM Eastern

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.

Solesence stock logo

Solesence NASDAQ:SLSN

$0.95 0.00 (-0.51%)
As of 08/28/2026 04:00 PM Eastern

Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.

USANA Health Sciences stock logo

USANA Health Sciences NYSE:USNA

$14.06 -0.04 (-0.28%)
As of 08/28/2026 03:58 PM Eastern

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas